Cover Image

Incidental findings on lung cancer screening: pictorial essay and systematic checklist

Lung cancer screening (LCS) programs are increasing worldwide. Incidental findings (IFs) on LCS are defined as low-dose CT findings unrelated to the primary purpose of identifying lung cancer. Most IFs on LCS are benign and clinically insignificant but are being increasingly recognized, and some req...

Full description

Saved in:
Bibliographic Details
Main Authors: Penha, Diana (Author) , Pinto, Erique (Author) , Monaghan, Colin (Author) , Hochhegger, Bruno (Author) , Marchiori, Edson (Author) , Taborda-Barata, Luís (Author) , Irion, Klaus (Author) , Ravara, Sofia (Author) , Kauczor, Hans-Ulrich (Author)
Format: Article (Journal)
Language:English
Published: 2022
In: Jornal Brasileiro de pneumologia
Year: 2022, Volume: 48, Issue: 1, Pages: 1-11
ISSN:1806-3756
DOI:10.36416/1806-3756/e20210371
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.36416/1806-3756/e20210371
Verlag, lizenzpflichtig, Volltext: http://www.jornaldepneumologia.com.br/details/3642/en-US/incidental-findings-on-lung-cancer-screening--pictorial-essay-and-systematic-checklist
Get full text
Author Notes:Diana Penha, Erique Pinto, Colin Monaghan, Bruno Hochhegger, Edson Marchiori, Luís Taborda-Barata, Klaus Irion, Sofia Ravara, Hans-Ulrich Kauczor
Description
Summary:Lung cancer screening (LCS) programs are increasing worldwide. Incidental findings (IFs) on LCS are defined as low-dose CT findings unrelated to the primary purpose of identifying lung cancer. Most IFs on LCS are benign and clinically insignificant but are being increasingly recognized, and some require urgent referral for further diagnostic workup. Other findings are expected and are known as smoking-related comorbidities, including COPD, cardiovascular disease, emphysema, and interstitial lung disease, and their diagnosis can have a significant impact on patient prognosis. The purpose of this pictorial essay is to illustrate the most common IFs on LCS, organized by organ. We will discuss the current literature on IFs on LCS, focusing on their prevalence, appropriate communication, and triggering of clinical pathway systems.
Item Description:Gesehen am 25.05.2022
Physical Description:Online Resource
ISSN:1806-3756
DOI:10.36416/1806-3756/e20210371

Similar Items